Three quarters of a mile from civilization
Views, analysis & commentary - essentially on venture capital & pharmaceutical industry
Showing posts with label
HBR
.
Show all posts
Showing posts with label
HBR
.
Show all posts
Sunday, November 10, 2013
So what's wrong if your drug-candidate is likely better-off as a dietary-supplement?
›
In a case-study , the Nov '13 issue of HBR showcases the dilemma of a R&D head grappling with the prospect of a failing clinical p...
Monday, July 8, 2013
I'm dumb with cool apps 'cos my phone ain't smart when I'm travelling overseas!
›
Ever heard an international traveler bitch about how cruel the data roaming tariffs can be - well, here i go... My comment on a recent po...
Monday, July 1, 2013
Cipla Ventures - What's the real story Gen-3?
›
Greed for quality & comprehension makes one less effective & less productive......... ........... Stash away those cudgels people,...
Monday, May 6, 2013
Dear HBR, defend your research!
›
In the May 2013 issue of HBR that has a ‘spotlight on entrepreneurship’, Adi Ignatius observes in the very first paragraph of his editoria...
Tuesday, March 5, 2013
What could VCs learn from the recent pharma deals involving biotechs with very early-assets?
›
My response on the blog post " Preclinical Biotech Structured Deals: Reflections on 2013′s Solid Start" by Bruce Booth - post...
›
Home
View web version
